
    
      This study is a retrospective, multi-center, open label study evaluating SimpliDerm and other
      human acellular dermal matrices in breast reconstruction.

      A total of up to 300 patients who underwent direct to implant (one stage) or two-stage
      unilateral or bilateral breast reconstruction with SimpliDerm an other HADMs at the time of
      implant or TE placement.

      Data will be collected for a minimum of one post-surgical visit after direct implant or
      exchange. If more visits are available, data from those visits will be collected as well.
    
  